Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer of 8 March 2016 to Question 29649, how patients whose clinical commissioning group has decided not to fund the provision of Sativex can access that medication.

Where a treatment is not routinely funded by a clinical commissioning group (CCG), the CCG is required to have systems in place to consider individual funding requests from clinicians who believe their patient would benefit from that treatment due to their clinical exceptionality.

Patients also have the choice of being treated privately.